1.png
 

Leveraging NPS to measure visual tracking impairments
Rebion’s Traq.™ device uses Neural Performance Scanning (NPS) to support clinical research focused on visual tracking, with the goal of translating these insights into future clinical tools.

Traq is currently investigational and not available for sale in the United States

 
 
 
AdobeStock_185919104.jpg